These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 1708813

  • 1. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14.
    Wright SD, Ramos RA, Hermanowski-Vosatka A, Rockwell P, Detmers PA.
    J Exp Med; 1991 May 01; 173(5):1281-6. PubMed ID: 1708813
    [Abstract] [Full Text] [Related]

  • 2. Lipopolysaccharide enhances CD11b/CD18 function but inhibits neutrophil aggregation.
    Lynam EB, Simon SI, Rochon YP, Sklar LA.
    Blood; 1994 Jun 01; 83(11):3303-11. PubMed ID: 7514906
    [Abstract] [Full Text] [Related]

  • 3. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
    Troelstra A, de Graaf-Miltenburg LA, van Bommel T, Verhoef J, Van Kessel KP, Van Strijp JA.
    J Immunol; 1999 Apr 01; 162(7):4220-5. PubMed ID: 10201950
    [Abstract] [Full Text] [Related]

  • 4. Lipopolysaccharide binding protein and CD14 interaction induces tumor necrosis factor-alpha generation and neutrophil sequestration in lungs after intratracheal endotoxin.
    Ishii Y, Wang Y, Haziot A, del Vecchio PJ, Goyert SM, Malik AB.
    Circ Res; 1993 Jul 01; 73(1):15-23. PubMed ID: 7685250
    [Abstract] [Full Text] [Related]

  • 5. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists.
    Lynn WA, Raetz CR, Qureshi N, Golenbock DT.
    J Immunol; 1991 Nov 01; 147(9):3072-9. PubMed ID: 1717586
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
    Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD.
    J Exp Med; 1994 Jan 01; 179(1):269-77. PubMed ID: 7505800
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro regulation of Mac-1 expression on bovine polymorphonuclear leukocytes by endotoxin and tumor necrosis factor-alpha at different stages of lactation.
    Diez-Fraile A, Meyer E, Duchateau L, Paape MJ, Burvenich C.
    Can J Vet Res; 2004 Jul 01; 68(3):232-5. PubMed ID: 15352552
    [No Abstract] [Full Text] [Related]

  • 11. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.
    Schumann RR.
    Res Immunol; 1992 Jan 01; 143(1):11-5. PubMed ID: 1373512
    [Abstract] [Full Text] [Related]

  • 12. Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils.
    Neuman E, Huleatt JW, Jack RM.
    J Immunol; 1990 Nov 15; 145(10):3325-32. PubMed ID: 1977799
    [Abstract] [Full Text] [Related]

  • 13. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.
    Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ.
    J Exp Med; 1992 Jun 01; 175(6):1697-705. PubMed ID: 1375269
    [Abstract] [Full Text] [Related]

  • 14. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
    Kitchens RL, Ulevitch RJ, Munford RS.
    J Exp Med; 1992 Aug 01; 176(2):485-94. PubMed ID: 1380063
    [Abstract] [Full Text] [Related]

  • 15. Interactions of lipopolysaccharide with neutrophils in blood via CD14.
    Weingarten R, Sklar LA, Mathison JC, Omidi S, Ainsworth T, Simon S, Ulevitch RJ, Tobias PS.
    J Leukoc Biol; 1993 May 01; 53(5):518-24. PubMed ID: 7684764
    [Abstract] [Full Text] [Related]

  • 16. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
    Tobias PS, Soldau K, Kline L, Lee JD, Kato K, Martin TP, Ulevitch RJ.
    J Immunol; 1993 Apr 01; 150(7):3011-21. PubMed ID: 7681085
    [Abstract] [Full Text] [Related]

  • 17. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.
    Haziot A, Tsuberi BZ, Goyert SM.
    J Immunol; 1993 Jun 15; 150(12):5556-65. PubMed ID: 7685797
    [Abstract] [Full Text] [Related]

  • 18. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide.
    Bagasra O, Wright SD, Seshamma T, Oakes JW, Pomerantz RJ.
    Proc Natl Acad Sci U S A; 1992 Jul 15; 89(14):6285-9. PubMed ID: 1378624
    [Abstract] [Full Text] [Related]

  • 19. Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2.
    Doerfler ME, Weiss J, Clark JD, Elsbach P.
    J Clin Invest; 1994 Apr 15; 93(4):1583-91. PubMed ID: 7512985
    [Abstract] [Full Text] [Related]

  • 20. Interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) enhance lipopolysaccharide binding to neutrophils via CD14.
    Takeshita S, Nakatani K, Takata Y, Kawase H, Sekine I, Yoshioka S.
    Inflamm Res; 1998 Mar 15; 47(3):101-3. PubMed ID: 9562334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.